Literature DB >> 15470855

Role of diastole in left ventricular function, I: Biochemical and biomechanical events.

Penelope S Villars1, Shannan K Hamlin, Andrew D Shaw, Joseph T Kanusky.   

Abstract

Left ventricular diastolic function plays an important role in cardiac physiology. Lusitropy, the ability of the cardiac myocytes to relax, is affected by both biochemical events within the myocyte and biomechanical events in the left ventricle. Beta-adrenergic stimulation alters diastole by enhancing the phosphorylation of phospholamban, a substrate within the myocyte that increases the uptake of calcium ions into the sarcoplasmic reticulum, increasing the rate of relaxation. Troponin I, a regulatory protein involved in the coupling of excitation to contraction, is vital to maintaining the diastolic state; depletion of troponin I can produce diastolic dysfunction. Other biochemical events, such as defects in the voltage-sensitive release mechanism or in inositol triphosphate calcium release channels, have also been implicated in altering diastolic tone. Extracellular collagen determines myocardial stiffness; impaired glucose tolerance can induce an increase in collagen cross-linking and lead to higher end-diastolic pressures. The passive properties of the left ventricle are most accurately measured during the diastasis and atrial contraction phases of diastole. These phases of the cardiac cycle are the least affected by volume status, afterload, inherent viscoelasticity, and the inotropic state of the myocardium. Diastolic abnormalities can be conceptualized by using pressure-volume loops that illustrate myocardial work and both diastolic and systolic pressure-volume relationships. The pressure-volume model is an educational tool that can be used to demonstrate isolated changes in preload, afterload, inotropy, and lusitropy and their interaction.

Entities:  

Mesh:

Year:  2004        PMID: 15470855

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  6 in total

1.  Intermediate Diastolic Velocity as a Parameter of Cardiac Dysfunction in Growth-Restricted Fetuses.

Authors:  Xiangna Tang; Edgar Hernandez-Andrade; Hyunyoung Ahn; Maynor Garcia; Homam Saker; Steven J Korzeniewski; Adi L Tarca; Lami Yeo; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2015-08-12       Impact factor: 2.587

2.  The fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis.

Authors:  Neil Hamill; Roberto Romero; Sonia Hassan; Wesley Lee; Stephen A Myers; Pooja Mittal; Juan Pedro Kusanovic; Mamtha Balasubramaniam; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Jimmy Espinoza; Francesca Gotsch; Luis F Goncalves; Shali Mazaki-Tovi; Offer Erez; Edgar Hernandez-Andrade; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2012-12-07       Impact factor: 8.661

3.  Influence of preoperative diastolic dysfunction on hemodynamics and outcomes of patients undergoing orthotopic liver transplantation.

Authors:  Zhen-Dong Xu; Hai-Tao Xu; Wei-Wei Li; Zui Zou; Xue-Yin Shi
Journal:  Int J Clin Exp Med       Date:  2013-05-22

4.  Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications.

Authors:  Péter Ferdinandy; István Baczkó; Péter Bencsik; Zoltán Giricz; Anikó Görbe; Pál Pacher; Zoltán V Varga; András Varró; Rainer Schulz
Journal:  Eur Heart J       Date:  2019-06-07       Impact factor: 29.983

5.  Different roles for contracture and calpain in calcium paradox-induced heart injury.

Authors:  Jian-Ying Zhang; Wei Tong; Feng Wu; Sheng-Hui Bi; Ming Xu; Zhen-Xiao Jin; Yang Yang; Xiao-Fan Jiang; Jing-Jun Zhou
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

6.  Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction.

Authors:  Bogdan Ioan Coculescu; Gabi Valeriu Dincă; Constantin Bălăeţ; Gheorghe Manole; Maria Bălăeţ; Cristina Mariana Stocheci
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.